Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics
PURPOSETo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.METHODSData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as pati...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2023-03-01
|
Series: | JCO Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/GO.22.00221 |
_version_ | 1797870043256586240 |
---|---|
author | Adedayo Joseph Abdul R. Shour Nwamaka N. Lasebikan Mutiu A. Jimoh Bolanle C. Adegboyega Emmanuella Nwachukwu Opeyemi Awofeso Azeezat Ajose Abiola Ibraheem Omolara Aminat Fatiregun Musa Ali-Gombe Usman M. Aliyu Abdallah Elsaid Kotkat Olusegun Abayomi Biyi-Olutunde Evaristus Oseiwe Oboh Ismail H. Zubairu Mohammad Rifat Haider Bankole Olatosi David Puthoff Adedayo A. Onitilo |
author_facet | Adedayo Joseph Abdul R. Shour Nwamaka N. Lasebikan Mutiu A. Jimoh Bolanle C. Adegboyega Emmanuella Nwachukwu Opeyemi Awofeso Azeezat Ajose Abiola Ibraheem Omolara Aminat Fatiregun Musa Ali-Gombe Usman M. Aliyu Abdallah Elsaid Kotkat Olusegun Abayomi Biyi-Olutunde Evaristus Oseiwe Oboh Ismail H. Zubairu Mohammad Rifat Haider Bankole Olatosi David Puthoff Adedayo A. Onitilo |
author_sort | Adedayo Joseph |
collection | DOAJ |
description | PURPOSETo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.METHODSData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as patients who reported their routine follow-up visits were converted to virtual visits because of COVID-19 (coded yes/no). Covariates included patient age, ethnicity, marital status, income, cancer treatment, service disruption, and cancer diagnosis/type. Stata/SE.v.17 (StataCorp, College Station, TX) was used to perform chi-square and logistic regression analyses. P values ≤ .05 were considered statistically significant.RESULTSThe majority of the 1,097 patients with cancer were female (65.7%) and age 55 years and older (35.0%). Because of COVID-19, 12.6% of patients' routine follow-ups were converted to virtual visits. More patients who canceled/postponed surgery (17.7% v 7.5%; P ≤ .001), radiotherapy (16.9% v 5.3%; P ≤ .001), and chemotherapy (22.8% v 8.5%; P ≤ .001), injection chemotherapy (20.6% v 8.7%; P ≤ .001) and those who reported being seen less by their doctor/nurse (60.3% v 11.4%; P ≤ .001) reported more follow-up conversions to virtual visits. In multivariate analyses, patients seen less by their doctors/nurses were 14.3 times more likely to have their routine follow-ups converted to virtual visits than those who did not (odds ratio, 14.33; 95% CI, 8.36 to 24.58).CONCLUSIONCOVID-19 caused many patients with cancer in Nigeria to convert visits to a virtual format. These conversions were more common in patients whose surgery, radiotherapy, chemotherapy, and injection chemotherapy treatments were canceled or postponed. Our findings suggest how COVID-19 affects cancer treatment services and the importance of collecting teleoncological care data in Nigeria. |
first_indexed | 2024-04-10T00:22:11Z |
format | Article |
id | doaj.art-7a94a34357f04490b37986d367735c4d |
institution | Directory Open Access Journal |
issn | 2687-8941 |
language | English |
last_indexed | 2024-04-10T00:22:11Z |
publishDate | 2023-03-01 |
publisher | American Society of Clinical Oncology |
record_format | Article |
series | JCO Global Oncology |
spelling | doaj.art-7a94a34357f04490b37986d367735c4d2023-03-15T19:59:01ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412023-03-01910.1200/GO.22.00221Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer ClinicsAdedayo Joseph0Abdul R. Shour1Nwamaka N. Lasebikan2Mutiu A. Jimoh3Bolanle C. Adegboyega4Emmanuella Nwachukwu5Opeyemi Awofeso6Azeezat Ajose7Abiola Ibraheem8Omolara Aminat Fatiregun9Musa Ali-Gombe10Usman M. Aliyu11Abdallah Elsaid Kotkat12Olusegun Abayomi Biyi-Olutunde13Evaristus Oseiwe Oboh14Ismail H. Zubairu15Mohammad Rifat Haider16Bankole Olatosi17David Puthoff18Adedayo A. Onitilo19NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WIUniversity of Nigeria Teaching Hospital, Enugu, NigeriaUniversity College Hospital, Ibadan, NigeriaNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaNational Hospital, Abuja, NigeriaHarvard Medical School, Boston, MAHarvard Medical School, Boston, MADivision of Hematology & Oncology, University of Illinois College of Medicine, Chicago, ILLagos State University Teaching Hospital (LASUTH), Lagos, NigeriaFederal Teaching Hospital, Gombe, NigeriaUsman Danfodiyo University Teaching Hospital, Sokoto, NigeriaNSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, NigeriaUniversity of Port-Harcourt Teaching Hospital, Rivers State, NigeriaUniversity of Benin Teaching Hospital, Edo, NigeriaAhmadu Bello University Teaching Hospital, Kaduna, NigeriaCancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WIMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WIMarshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WICancer Care and Research Center, Marshfield Clinic Health System, Marshfield, WIPURPOSETo examine cancer patients' perspectives on the impact of COVID-19 on teleoncology in Nigeria.METHODSData from a multicenter survey conducted at 15 outpatient clinics to 1,097 patients with cancer from April and July 2020 were analyzed. The study outcome was telemedicine, defined as patients who reported their routine follow-up visits were converted to virtual visits because of COVID-19 (coded yes/no). Covariates included patient age, ethnicity, marital status, income, cancer treatment, service disruption, and cancer diagnosis/type. Stata/SE.v.17 (StataCorp, College Station, TX) was used to perform chi-square and logistic regression analyses. P values ≤ .05 were considered statistically significant.RESULTSThe majority of the 1,097 patients with cancer were female (65.7%) and age 55 years and older (35.0%). Because of COVID-19, 12.6% of patients' routine follow-ups were converted to virtual visits. More patients who canceled/postponed surgery (17.7% v 7.5%; P ≤ .001), radiotherapy (16.9% v 5.3%; P ≤ .001), and chemotherapy (22.8% v 8.5%; P ≤ .001), injection chemotherapy (20.6% v 8.7%; P ≤ .001) and those who reported being seen less by their doctor/nurse (60.3% v 11.4%; P ≤ .001) reported more follow-up conversions to virtual visits. In multivariate analyses, patients seen less by their doctors/nurses were 14.3 times more likely to have their routine follow-ups converted to virtual visits than those who did not (odds ratio, 14.33; 95% CI, 8.36 to 24.58).CONCLUSIONCOVID-19 caused many patients with cancer in Nigeria to convert visits to a virtual format. These conversions were more common in patients whose surgery, radiotherapy, chemotherapy, and injection chemotherapy treatments were canceled or postponed. Our findings suggest how COVID-19 affects cancer treatment services and the importance of collecting teleoncological care data in Nigeria.https://ascopubs.org/doi/10.1200/GO.22.00221 |
spellingShingle | Adedayo Joseph Abdul R. Shour Nwamaka N. Lasebikan Mutiu A. Jimoh Bolanle C. Adegboyega Emmanuella Nwachukwu Opeyemi Awofeso Azeezat Ajose Abiola Ibraheem Omolara Aminat Fatiregun Musa Ali-Gombe Usman M. Aliyu Abdallah Elsaid Kotkat Olusegun Abayomi Biyi-Olutunde Evaristus Oseiwe Oboh Ismail H. Zubairu Mohammad Rifat Haider Bankole Olatosi David Puthoff Adedayo A. Onitilo Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics JCO Global Oncology |
title | Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics |
title_full | Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics |
title_fullStr | Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics |
title_full_unstemmed | Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics |
title_short | Examining Cancer Patients' Perceptions of the Impact of COVID-19 on Teleoncology: Findings From 15 Nigerian Outpatient Cancer Clinics |
title_sort | examining cancer patients perceptions of the impact of covid 19 on teleoncology findings from 15 nigerian outpatient cancer clinics |
url | https://ascopubs.org/doi/10.1200/GO.22.00221 |
work_keys_str_mv | AT adedayojoseph examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT abdulrshour examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT nwamakanlasebikan examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT mutiuajimoh examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT bolanlecadegboyega examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT emmanuellanwachukwu examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT opeyemiawofeso examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT azeezatajose examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT abiolaibraheem examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT omolaraaminatfatiregun examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT musaaligombe examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT usmanmaliyu examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT abdallahelsaidkotkat examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT olusegunabayomibiyiolutunde examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT evaristusoseiweoboh examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT ismailhzubairu examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT mohammadrifathaider examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT bankoleolatosi examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT davidputhoff examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics AT adedayoaonitilo examiningcancerpatientsperceptionsoftheimpactofcovid19onteleoncologyfindingsfrom15nigerianoutpatientcancerclinics |